ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "CyTOF"

  • Abstract Number: 2420 • 2017 ACR/ARHP Annual Meeting

    Mass Cytometry Analysis of CD4+ T Cells in Patients with Rheumatoid Arthritis

    Laura Su1, Daniel del Alcazar2 and Adam Marc2, 1University of Pennsylvania, Philadelphia, PA, 2Medicine, University of Pennsylvania, Philadelphia, PA

    Background/Purpose: CD4+ T cells play a key role in the initiation and progression of RA. Past studies have identified impaired function and regulation of several…
  • Abstract Number: 2637 • 2017 ACR/ARHP Annual Meeting

    A Novel Regulatory Antigen Presenting B Cell and Memory Regulatory T Cell Subsets Are Enriched during the Quiescent Phase of Childhood Onset Systemic Lupus Erythematosus

    Joo Guan Yeo1,2, Thaschawee Arkachaisri1,3, Lena Das1, Justin Hung Tiong Tan1, Jing Yao Leong2, Yun June Angela Tan4, Liyun Lai5, Loshinidevi D/O Thana Bathi2, Phyllis Chen2, Seck Choon Elene Lee1, Yun Xin Book1 and Salvatore Albani5,6, 1Rheumatology and Immunology Service, KK Women's and Children's Hospital, Singapore, Singapore, 2Singhealth Translational Immunology and Inflammation Centre (STIIC), Duke-NUS Medical School, Singapore, Singapore, 3Duke-NUS Medical School, Singapore, Singapore, 4Department of Paediatric Anaesthesia, KK Women's and Children's Hospital, Singapore, Singapore, 5SingHealth Translational Immunology and Inflammation Centre (STIIC), Duke-NUS Medical School, Singapore, Singapore, 6KK Women's and Children's Hospital, Singapore, Singapore

    Background/Purpose: Systemic Lupus Erythematosus (SLE) is a multi-factorial disease and the conventional oligo-dimensional investigative approach involving one or a few cell subsets at a time…
  • Abstract Number: 83 • 2017 ACR/ARHP Annual Meeting

    Whole Blood Stimulations Identify Elevated T Cell Cytokines and Altered Granulocyte/Dendritic Cell Signaling in SLE Patients with Variable Disease Activity

    Samantha Slight-Webb1, Krista M. Bean1, Holden T. Maecker2, Paul J. Utz3, Judith A. James4 and Joel M. Guthridge5, 1Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, 3Medicine, Stanford University School of Medicine, Stanford, CA, 4Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 5Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, OKC, OK

    Background/Purpose: Systemic lupus erythematosus (SLE) is characterized by loss of immune tolerance to self-antigens and periods of waxing and waning disease. The clinical aspects of…
  • Abstract Number: 297 • 2017 ACR/ARHP Annual Meeting

    Multiplexed Characterization of Circulating and Joint-Derived Human Neutrophils in Inflammatory Arthritis

    Ricardo Grieshaber Bouyer1, Olha Halyabar2, Anais Levescot1, Kacie Hoyt2, Lauren Henderson2 and Peter Nigrovic1,2, 1Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 2Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA

    Background/Purpose: Neutrophils are innate immune cells that play a central role in the initiation of inflammatory arthritis as well as mediating tissue damage. We sought…
  • Abstract Number: 759 • 2017 ACR/ARHP Annual Meeting

    Multi Dimensional Analysis of the Immunome in Systemic Sclerosis Reveals Functionally Related Abnormalities in MAIT and B Cell Compartments

    Bhairav Paleja1, Pavanish Kumar1, Suzan Saidin1, Ahmad Lajam2, Camillus Chua1, Liyun Lai1, Andrea Hsiu Ling Low2 and Salvatore Albani1, 1SingHealth Translational Immunology and Inflammation Centre (STIIC), Duke-NUS Medical School, Singapore, Singapore, 2Singapore General Hospital, Singapore, Singapore

    Background/Purpose: Systemic sclerosis (SSc) is an autoimmune disease characterised by excessive fibrosis of skin and internal organs, and vascular dysfunction. Association of T and B…
  • Abstract Number: 953 • 2017 ACR/ARHP Annual Meeting

    Persistence of Pathogenic CD4 Memory T Cells Revealed through Cytometry Time of Flight in Juvenile Idiopathic Arthritic Patients with Disease Resurgence upon Withdrawal of Anti-TNFA Biologics

    Jing Yao Leong1, Joo Guan Yeo2, Phyllis Chen3, Liyun Lai4, Fauziah Ally5, Loshinidevi D/O Thana Bathi3, Justin Hung Tiong Tan2, Thaschawee Arkachaisri2, Femke van Wijk6, Salvatore Albani4, Daniel J Lovell7 and Gerdien Mijnheer8, 1SingHealth Translational Immunology and Inflammation Centre, Singapore Health Services Pte Ltd, Singapore, Singapore, 2Rheumatology and Immunology Service, KK Women's and Children's Hospital, Singapore, Singapore, 3Singhealth Translational Immunology and Inflammation Centre (STIIC), Duke-NUS Medical School, Singapore, Singapore, 4SingHealth Translational Immunology and Inflammation Centre (STIIC), Duke-NUS Medical School, Singapore, Singapore, 5STIIC, SingHealth Translational Immunology and Inflammation Centre, Singapore, Singapore, 6University Medical Center Utrecht, Utrecht, Netherlands, 7Rheumatology, PRCSG - Cincinnati Children's Hospital Medical Center, Cinncinnati, OH, 81Laboratory of Translational Immunology, Department of Paediatric Immunology, , The Netherlands, University Medical Centre Utrecht, Wilhelmina Children’s Hospital, Utrecht, Netherlands

    Background/Purpose: Treatment of polyarticular JIA with anti-TNFA biologics has experienced significant success, with up to 80% of patients demonstrating clinically meaningful efficacy. Yet concerns regarding…
  • Abstract Number: 1405 • 2017 ACR/ARHP Annual Meeting

    Using Flow and Mass Cytometry to Demonstrate Robust Tissue Processing to Query Molecular Heterogeneity in Phase 1 of the Accelerating Medicines Partnership (AMP) – RA Network

    Kevin Wei1, Deepak Rao2, Fan Zhang3, Chamith Fonseka3, Kamil Slowikowski3, Joshua Keegan4, Laura T. Donlin5, Jason Turner6, Mandy J. McGeachy7, Nida Meednu8, David Lieb9, Stephen Kelly10, Susan M. Goodman11, David L. Boyle12, William H. Robinson13, Paul J. Utz14, Gary S. Firestein15, Harris Perlman16, Edward F. DiCarlo17, Costantino Pitzalis10, Andrew Filer18, Brendan Boyce19, Ellen M. Gravallese20, Chad Nusbaum21, James Lederer4, Nir Hacohen22,23,24, Peter Gregersen25, Larry W. Moreland26, Michael Holers27, Vivian P. Bykerk28, Soumya Raychaudhuri3, Michael Brenner29 and Jennifer H. Anolik8, 1Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 2Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 3Divisions of Genetics and Rheumatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 4Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 5Arthritis and Tissue Degeneration Program and the David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY, 6Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom, 7Medicine, University of Pittsburgh, Pittsburgh, PA, 8Medicine- Allergy, Immunology and Rheumatology, University of Rochester Medical Center, Rochester, NY, 9Broad Institute, Cambridge, MA, 10Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London, School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom, 11Medicine, Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, 12University of California San Diego, La Jolla, CA, 13Stanford University School of Medicine, Stanford, CA, 14Medicine, Stanford University School of Medicine, Stanford, CA, 15Medicine, University of California San Diego, La Jolla, CA, 16Department of Medicine, Division of Rheumatology, Northwestern University Feinberg School of Medicine, Northwestern University Feinberg School of Medicine,, Chicago, IL, 17Laboratory Medicine, Hospital for Special Surgery, New York, NY, 18Institute of Inflammation and Ageing (IIA), University of Birmingham, Birmingham, United Kingdom, 19University of Rochester Medical Center, Rochester, NY, 20Lazare Research Bldg, University of Massachusetts Medical School, Worcester, MA, 21The Broad Institute and Harvard, Cambridge, MA, 22Harvard Medical School, Boston, MA, 23Massachusetts General Hospital, Charlestown, MA, 24Broad Institute of MIT and Harvard, Cambridge, MA, 25The Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY, 26Rheumatology & Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 27Medicine, Division of Rheumatology, University of Colorado Denver, Aurora, CO, 28Divison of Rheumatology, Hospital for Special Surgery, New York, NY, 29Brigham and Women's Hospital and Harvard Medical School, Boston, MA

    Background/Purpose: Discovery and application of new therapies for rheumatoid arthritis (RA) has been hampered by multiple factors, including disease heterogeneity and the lack of well…
  • Abstract Number: 133 • 2017 Pediatric Rheumatology Symposium

    3-D Explant Method Facilitates the Study of Lymphocytes in Synovium and Reveals a Population of Resident Memory-Like T Cells in Rheumatoid Arthritis

    Lauren Henderson1, Deepak Rao2, Nikola Teslovich3,4, Sandra King5, Fumitaka Mizoguchi6, Sarah Ameri6, Allyn Morris7, Christopher Elco5, Margaret Chang8, Anais Levescot9, James Lederer10, Scott Martin11, Barry Simmons11, John Wright11, Michael Brenner2, Soumya Raychaudhuri12,13,14,15,16, Robert Fuhlbrigge17 and Peter Nigrovic1,18, 1Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA, 2Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 3Program in Medical and Population Genetics, Broad Institute of Massachusetts Technical Institute and Harvard University, Cambridge, MD, 4Divisions of Genetics and Rheumatology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, 5Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 6Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 7Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA, 8Division of Immunology, Boston Children's Hospital, Boston, MA, 9Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, boston, MA, 10Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 11Department of Orthopedic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 12Divisions of Genetics and Rheumatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 13Program in Medical and Population Genetics, Broad Institute of Massachusetts Technical Institute, Harvard University, Cambridge, MA, 14Partners Center for Personalized Genetic Medicine, Boston, MA, 15Institute of Inflammation and Repair, University of Manchester, Manchester, United Kingdom, 16Rheumatology Unit, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden, 17Children's Hospital Colorado, Aurora, CO, 18Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

    Background/Purpose:  Tissue resident memory T (TRM) cells survive indefinitely in barrier tissues and mediate swift immunologic memory responses at sites of microbe entry. TRM cells…
  • Abstract Number: 1557 • 2016 ACR/ARHP Annual Meeting

    3-D Explant Method Facilitates the Study of Lymphocytes in Synovium and Reveals a Population of Resident Memory-like T Cells in Rheumatoid Arthritis

    Lauren Henderson1, Deepak Rao2, Nikola Teslovich3,4, Sandra King5, Fumitaka Mizoguchi6, Sarah Ameri6, Allyn Morris7, Christopher Elco8, James Lederer9, Scott Martin10, Barry Simmons10, John Wright10, Michael Brenner2, Soumya Raychaudhuri11,12,13,14,15, Peter Nigrovic1,16 and Robert Fuhlbrigge17,18, 1Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA, 2Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 3Divisions of Genetics and Rheumatology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, 4Brigham and Women's Hospital and Harvard Medical School, Cambridge, MA, 5Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 6Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 7Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA, 8Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 9Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 10Department of Orthopedic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 11Divisions of Genetics and Rheumatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 12Program in Medical and Population Genetics, Broad Institute of Massachusetts Technical Institute, Harvard University, Cambridge, MA, 13Partners Center for Personalized Genetic Medicine, Boston, MA, 14Rheumatology Unit, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden, 15Institute of Inflammation and Repair, University of Manchester, Manchester, United Kingdom, 16Rheumatology, Immunology, and Allergy, Brigham and Women’s Hospital, Boston, MA, 17Immunology, Boston Children's Hospital, Boston, MA, 18Dermatology, Brigham and Women’s Hospital, Boston, MA

    Background/Purpose: Tissue resident memory T (TRM) cells survive indefinitely in barrier tissues and mediate swift immunologic memory responses at sites of microbe entry. TRM cells…
  • Abstract Number: 1823 • 2016 ACR/ARHP Annual Meeting

    African American and European American SLE Patients with Variable Disease Activity Reveal Distinct Differences in CD4+ T Cell and Monocyte Pathways

    Samantha Slight-Webb1, Rufei Lu2, Krista M. Bean1, Holden T. Maecker3, Paul J. Utz4, Joel M. Guthridge5 and Judith A. James6, 1Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, 4Medicine, Stanford University School of Medicine, Stanford, CA, 5Arthritis & Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 6Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK

    Background/Purpose: Systemic lupus erythematosus (SLE) is an autoimmune disorder with both genetic and environmental contributions to disease etiology. Patients with different ancestral backgrounds have different…
  • Abstract Number: 1824 • 2016 ACR/ARHP Annual Meeting

    Mycophenolate Mofetil Use Associates with Unique Biologic Changes in B Cell and T Regulatory Cell Pathways in SLE Patients

    Samantha Slight-Webb1, Rufei Lu2, Krista M. Bean1, Holden T. Maecker3, Paul J. Utz4, Joel M. Guthridge5 and Judith A. James6, 1Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, 4Medicine, Stanford University School of Medicine, Stanford, CA, 5Arthritis & Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 6Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK

    Background/Purpose:  The management of systemic lupus erythematosus (SLE) is complicated by a heterogeneous clinical presentation. Currently, mycophenolate mofetil (MMF) is a commonly used medication to…
  • Abstract Number: 1840 • 2016 ACR/ARHP Annual Meeting

    A Dichotomy of Regulatory Immunome Is Related to Disease Activity in Juvenile Systemic Lupus Erythematosus

    Joo Guan Yeo1,2, Thaschawee Arkachaisri1,3, Justin Hung Tiong Tan1, Jing Yao Leong4, Lena Das1, Loshinidevi D/O Thana Bathi2, Phyllis Chen2 and Salvatore Albani3,4, 1Rheumatology and Immunology, KK Women's and Children's Hospital, Singapore, Singapore, 2Singhealth Translational Immunology and Inflammation Centre, Singapore Health Services Pte Ltd, Singapore, Singapore, 3Duke-National University of Singapore Medical School, Singapore, Singapore, 4SingHealth Translational Immunology and Inflammation Centre, Singapore Health Services Pte Ltd, Singapore, Singapore

    Background/Purpose: The pathogenesis of SLE involves disturbances to the homeostatic balance between the immune effector and regulatory system. The conventional mono-dimensional mechanistic interrogation of one…
  • Abstract Number: 2417 • 2016 ACR/ARHP Annual Meeting

    High Dimensional Interrogation of the T Cell Immunome in Polyarticular Juvenile Idiopathic Arthritis Patients 

    Jing Yao Leong1, Justin Tiong2, Joo Guan Yeo2,3, Liyun Lai1, Phyllis Chen3, Loshinidevi D/O Thana Bathi3, Thaschawee Arkachaisri2, Daniel J Lovell4 and Salvatore Albani1,5, 1SingHealth Translational Immunology and Inflammation Centre, Singapore Health Services Pte Ltd, Singapore, Singapore, 2Rheumatology and Immunology, KK Women's and Children's Hospital, Singapore, Singapore, 3Singhealth Translational Immunology and Inflammation Centre, Singapore Health Services Pte Ltd, Singapore, Singapore, 4PRCSG Cincinnati Children's Hospital Medical Center, Cinncinnati, OH, 5Duke-National University of Singapore Medical School, Singapore, Singapore

    Background/Purpose: Clinical management of polyarticular JIA with anti-TNF-alpha has been met with moderate success, with up to 50% of patients demonstrating clinically meaningful efficacy. Concerns…
  • Abstract Number: 3111 • 2016 ACR/ARHP Annual Meeting

    Pathogenic T Cell Responses in Systemic Sclerosis Is Shaped By Novel Cytokine Axis in the Microenvironment: A Multidimensional, High Throughput Analysis

    Hari Balaji1, Andrea HL Low2, Chieh Hwee Ang3, Raymond Ong Jr.4, Juntao Li5, Camillus Chua3, Liyun Lai3, Suzan Saidin3 and Salvatore Albani3, 1SingHealth Translational Immunology and Inflammation Centre, Singapore, Singapore, 2-, Singapore, Singapore, 3SingHealth Translational Immunology and Inflammation Centre, Singapore Health Services Pte Ltd, Singapore, Singapore, 4Singhealth Translational Immunology and Inflammation Centre (STIIC), Singapore Health Services Pte Ltd, Singapore, Singapore, 5Duke-National University of Singapore Graduate Medical School, Singapore, Singapore

    Background/Purpose: Pathogenic immune responses can be profoundly shaped by the interplay between the periphery and the microenvironment. In this work we aimed at defining the…
  • Abstract Number: 3216 • 2016 ACR/ARHP Annual Meeting

    Integrated High-Dimensional Analyses Reveal a Pathologically Expanded ‘Peripheral’ B Cell-Helper T Cell Population in Rheumatoid Arthritis

    Deepak Rao1, Michael Gurish2, Kamil Slowikowski3, Chamith Fonseka2, Jennifer Marshall4, Yanyan Liu5, Laura T. Donlin6, Lauren Henderson7, Fumitaka Mizoguchi8, Nikola Teslovich9, Michael Weinblatt10, Elena Massarotti10, Jonathan Coblyn11, Simon M. Helfgott10, Yvonne C. Lee12, Derrick J. Todd10, Vivian P. Bykerk13, Susan M. Goodman14, Alessandra B. Pernis15, Lionel Ivashkiv14, Elizabeth W. Karlson10, Peter Nigrovic9, Andrew Filer16, Christopher Buckley17, James Lederer18, Soumya Raychaudhuri19 and Michael Brenner1, 1Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 2Division of Rheumatology, Immunology, Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 3Divisions of Rheumatology and Genetics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 4Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom, 5Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 6Arthritis and Tissue Degeneration Program and the David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY, 7Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA, 8Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan, 9Brigham and Women's Hospital and Harvard Medical School, Cambridge, MA, 10Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 11Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 12Rheumatology Immunology & Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 13Divison of Rheumatology, Hospital for Special Surgery, New York, NY, 14Medicine, Hospital for Special Surgery, New York, NY, 15David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY, 16University of Birmingham, Birmingham, United Kingdom, 17Rheumatology, University of Birmingham, Birmingham, United Kingdom, 18Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 19Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Determining the pathologic functions of T cells that infiltrate target tissues remains a central challenge in autoimmune diseases. In rheumatoid arthritis (RA), the formation…
  • « Previous Page
  • 1
  • 2
  • 3
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology